Cargando…
Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies
NLCs have provoked the incessant impulsion for the development of safe and valuable drug delivery systems owing to their exceptional physicochemical and then biocompatible characteristics. Throughout the earlier period, a lot of studies recounting NLCs based formulations have been noticeably increas...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463508/ https://www.ncbi.nlm.nih.gov/pubmed/34588846 http://dx.doi.org/10.1016/j.jsps.2021.07.015 |
_version_ | 1784572411246542848 |
---|---|
author | Elmowafy, Mohammed Al-Sanea, Mohammad M. |
author_facet | Elmowafy, Mohammed Al-Sanea, Mohammad M. |
author_sort | Elmowafy, Mohammed |
collection | PubMed |
description | NLCs have provoked the incessant impulsion for the development of safe and valuable drug delivery systems owing to their exceptional physicochemical and then biocompatible characteristics. Throughout the earlier period, a lot of studies recounting NLCs based formulations have been noticeably increased. They are binary system which contains both solid and liquid lipids aiming to produce less ordered lipidic core. Their constituents particularly influence the physicochemical properties and effectiveness of the final product. NLCs can be fabricated by different techniques which are classified according to consumed energy. More utilization NLCs is essential due to overcome barriers surrounded by the technological procedure of lipid-based nanocarriers’ formulation and increased information of the core mechanisms of their transport via various routes of administration. They can be used in different applications and by different routes such as oral, cutaneous, ocular and pulmonary. This review article seeks to present an overview on the existing situation of the art of NLCs for future clinics through exposition of their applications which shall foster their lucid use. The reported records evidently demonstrate the promise of NLCs for innovate therapeutic applications in the future. |
format | Online Article Text |
id | pubmed-8463508 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-84635082021-09-28 Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies Elmowafy, Mohammed Al-Sanea, Mohammad M. Saudi Pharm J Review NLCs have provoked the incessant impulsion for the development of safe and valuable drug delivery systems owing to their exceptional physicochemical and then biocompatible characteristics. Throughout the earlier period, a lot of studies recounting NLCs based formulations have been noticeably increased. They are binary system which contains both solid and liquid lipids aiming to produce less ordered lipidic core. Their constituents particularly influence the physicochemical properties and effectiveness of the final product. NLCs can be fabricated by different techniques which are classified according to consumed energy. More utilization NLCs is essential due to overcome barriers surrounded by the technological procedure of lipid-based nanocarriers’ formulation and increased information of the core mechanisms of their transport via various routes of administration. They can be used in different applications and by different routes such as oral, cutaneous, ocular and pulmonary. This review article seeks to present an overview on the existing situation of the art of NLCs for future clinics through exposition of their applications which shall foster their lucid use. The reported records evidently demonstrate the promise of NLCs for innovate therapeutic applications in the future. Elsevier 2021-09 2021-07-21 /pmc/articles/PMC8463508/ /pubmed/34588846 http://dx.doi.org/10.1016/j.jsps.2021.07.015 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Elmowafy, Mohammed Al-Sanea, Mohammad M. Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies |
title | Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies |
title_full | Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies |
title_fullStr | Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies |
title_full_unstemmed | Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies |
title_short | Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies |
title_sort | nanostructured lipid carriers (nlcs) as drug delivery platform: advances in formulation and delivery strategies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463508/ https://www.ncbi.nlm.nih.gov/pubmed/34588846 http://dx.doi.org/10.1016/j.jsps.2021.07.015 |
work_keys_str_mv | AT elmowafymohammed nanostructuredlipidcarriersnlcsasdrugdeliveryplatformadvancesinformulationanddeliverystrategies AT alsaneamohammadm nanostructuredlipidcarriersnlcsasdrugdeliveryplatformadvancesinformulationanddeliverystrategies |